About Us

• The Company was established.

• R&D of Laparoscopic Single Port Multi-Channel Access Platform commenced.

• R&D of Bladder Cryoablation System commenced.

• R&D of Anti-Gastroesophageal Reflux System commenced.

• R&D of Pulmonary Nodule Localization Needle commenced.

• Registration application of Laparoscopic Single Port Multi-Channel Access Platform submitted to NMPA.

• ''Innovative Medical Device'' for Bladder Cryoablation System assessed and considered by NMPA.

• Laparoscopic Single Port Multi-Channel Access Platform approved by NMPA.

• First case of Bladder Cryoablation System trial enrolled.

• Registration application of Pulmonary Nodule Localization Needle submitted to NMPA.

• R&D of Endoscopic Clip for Anastomosis commenced.

• R&D of Cryoablation System for Malignant Airway Stenosis commenced.

• R&D of Cryoablation System for Asthma commenced.

• High-Tech Enterprise Certificate awarded.

• R&D of Cryospray System for COPD commenced.

• R&D of Cryospray System for Esophageal Cancer commenced.

• Pulmonary Nodule Localization Needle approved by NMPA.

• ''Innovative Medical Device'' for Endoscopic Clip for Anastomosis assessed and considered by NMPA in ZheJiang province.

• First case of Endoscopic Clip for Anastomosis trial enrolled.

• Bladder Cryoablation System trial completed.

• Second place in ''Maker in China'', the NingBo SME Innovation and Entrepreneurship Competition, awarded.

• Strategic merger with Cryofocus completed.

• Endoscopic Clip for Anastomosis trial completed.

• Registration application of Bladder Cryoablation System submitted to NMPA.

• Registration application of Endoscopic Clip for Anastomosis submitted to NMPA.

• Bladder Cryoablation System approved by NMPA.

• Endoscopic anastomosis clip approved by NMPA.

• Asthma Cryoablation Systementered into the confirmatory clinical trial phase.

• COPD Cryospray System entered into the confirmatory clinical trial phase.

• Disposable Multichannel Single-port Laparoscopic Trocar obtained the NMPA registration certificate.

• Cryofocus and BSC International Medical Trading (Shanghai) Co., Ltd. reached a strategic cooperation on respiratory intervention products.

• In the field of peripheral pulmonary nodule treatment, comprehensive cooperation was carried out with Guangzhou Institute of espiratory Health.

• Induced into Ningbo "Golden Seed" Plan Intermediate Library Enterprise.
  

• Cryo-balloon System obtained the NMPA registration certificates.

• Asthma cryotherapy ablation obtains FDA breakthrough medical device designation.

• Gastroesophageal reflux system obtains registration certificate.

Endoscope catheter obtained registration certificate.